Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 9/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 8/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 7/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 7/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 7/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 6/20 | 1.00 |
| ▸ | XDH | P47989 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 6/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 5/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | APP | P05067 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HPGD | P15428 | 5/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kaempferol SCHEMBL29378805 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL18817 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL30655455 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL34461912 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL31256029 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL30544809 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL31749037 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL31577746 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL17237761 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 | |
| Kaempferol SCHEMBL38651062 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023198519-A1 | CROCUS SATIVUS FLOWER EXTRACTS, COMPOSITIONS COMPRISING SAME, AND USES THEREOF IN ORAL CARE | ISP INVESTMENTS LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| CN-105301123-B | A kind of HPLC detection methods of Liangfu class preparation | 成都中医药大学 | 2017-09-29 | — | — | CN | disclosed |
| US-9040673-B2 | Synthesis and identification of novel RSK-specific inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2015-05-26 | — | — | US | disclosed |
| US-20120245112-A1 | SYNTHESIS AND IDENTIFICATION OF NOVEL RSK-SPECIFIC INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-09-27 | — | — | US | disclosed |
| WO-2011019995-A2 | SYNTHESIS AND IDENTIFICATION OF NOVEL RSK-SPECIFIC INHIBITORS | HECHT SIDNEY M (US) | 2011-02-17 | — | — | WO | disclosed |
| US-20080070971-A1 | Medical Use of Bilirubin and its Structural Analogues | WANG XIANG H | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070971-A1 | Medical Use of Bilirubin and its Structural Analogues | RBP1, RBP4, AGER | MEN1 2977/4885KMT2A 4282/4885CYP1A2 82/4885 |
| US-20120245112-A1 | SYNTHESIS AND IDENTIFICATION OF NOVEL RSK-SPECIFIC INHIBITORS | ULK1, RPS6KA1, RPS6KA2 | MEN1 3676/4885KMT2A 2751/4885CYP1A2 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.